Neuropsychopharmacology
- Insular cortex subregions have distinct roles in cued heroin seeking after extinction learning and prolonged withdrawal in rats2 years ago
- Dnmt3a1 regulates hippocampus-dependent memory via the downstream target Nrp12 years ago
- Does steroid increase LPS-induced sickness behaviors?2 years ago
- IN MEMORIAM—Brian E. Leonard PhD DSc MRIA2 years ago
- Brain-based graph-theoretical predictive modeling to map the trajectory of anhedonia, impulsivity, and hypomania from the human functional connectome2 years ago
- Lifespan development of thalamic nuclei and characterizing thalamic nuclei abnormalities in schizophrenia using normative modeling2 years ago
- Elevated dorsal medial prefrontal cortex to lateral habenula pathway activity mediates chronic stress-induced depressive and anxiety-like behaviors2 years ago
Journal of Psychopharmacology
- Enhancement of the GluN2B subunit of glutamatergic NMDA receptors in rat brain areas after cocaine abstinence5 years ago
- Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis5 years ago
- Dopaminergic and noradrenergic modulation of stress-induced alterations in brain activation associated with goal-directed behaviour5 years ago
- Three regulatory compliant test systems show no signs of MDMA-related genotoxicity5 years ago
- Over the counter low-dose cannabidiol: A viewpoint from the ACRE Capacity Building Group5 years ago
- Which are the demographic and clinical characteristics of patients who respond to subcutaneous esketamine?5 years ago
- Effects of benzodiazepine and orexin receptor antagonist on cognitive function revealed by auditory event-related potentials5 years ago
European Neuropsychopharmacology
- Comparative effectiveness of antipsychotic monotherapy and polypharmacy in schizophrenia patients with clozapine treatment: A nationwide, health insurance data-based study4 years ago
- Association between CACNA1C gene rs100737 polymorphism and glutamatergic neurometabolites in bipolar disorder4 years ago
- Trajectory of cognitive impairments over 1 year after COVID-19 hospitalisation: pattern, severity, and functional implications4 years ago
- Lithium: What can we do to overcome the discrepancies between evidence, guideline recommendations and clinical practice?4 years ago
- Mechanisms of action of anti-bipolar drugs4 years ago
- Pharmacological characterization of 3,4-methylenedioxamphetamine (MDA) analogs and two amphetamine-based compounds: N,α-DEPEA and DPIA4 years ago
- Is it time to change the term negative symptoms?4 years ago